Solubilization and characterization of high and low affinity pirenzepine binding sites from rat cerebral cortex
Open Access
- 19 July 1985
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 85 (3) , 697-703
- https://doi.org/10.1111/j.1476-5381.1985.tb10566.x
Abstract
1 An apparently monomeric form of the digitonin-solubilized muscarinic acetylcholine receptor from the rat cerebral cortex retains a high affinity of 7 × 107 M−1 for pirenzepine. 2 Muscarinic receptor binding sites in the rat cerebral cortex with a low affinity for pirenzepine are solubilized with relatively little change in affinity. 3 The ability of pirenzepine to distinguish between subtypes of muscarinic binding site in the cerebral cortex is manifest in both the membrane-bound and soluble state.This publication has 20 references indexed in Scilit:
- Selective muscarinic receptor antagonistsTrends in Pharmacological Sciences, 1984
- [3H]Pirenzepine identifies putative M1 muscarinic receptors in human stellate gangliaBrain Research, 1984
- A unique regulatory profile and regional distribution of [3H]pirenzepine binding in the rat provide evidence for distinct M1 and M2 muscarinic receptor subtypesLife Sciences, 1983
- Central administration of the muscarinic receptor subtype - selective antagonist pirenzepine selectively impairs passive avoidance learning in the mouseJournal of Pharmacy and Pharmacology, 1983
- Muscarinic receptor subclassesTrends in Pharmacological Sciences, 1983
- Muscarinic receptors revisitedTrends in Neurosciences, 1983
- Muscarinic receptor subtypes: M1 and M2 biochemical and functional characterizationLife Sciences, 1982
- [3H] pirenzepine selectively identifies a high affinity population of muscarinic cholinergic receptors in the rat cerebral cortexLife Sciences, 1982
- Two populations of binding sites for muscarinic antagonists in the rat heartEuropean Journal of Pharmacology, 1981
- Pirenzepine distinguishes between different subclasses of muscarinic receptorsNature, 1980